Zavesca (Miglustat)
- Medicine Name: Zavesca
- API: Miglustat
- Dosage Form & Strength: Capsules: 100 mg
- Manufactured By: Actelion Pharmaceuticals, Inc.
Zavesca (miglustat) is a glucosylceramide synthase inhibitor used as monotherapy for the treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option.
Recommended Dosage: The recommended dosage for adult patients with type 1 Gaucher disease is one 100 mg capsule administered orally three times daily at regular intervals. If any dose is missed, the next capsule needs to be taken at the next scheduled time. It may be required to reduce the dose to a single 100 mg capsule once or twice daily in some patients because of side effects, such as tremors or diarrhea.
- Zavesca 100 mg capsules can cause liver enzyme elevations, which may indicate liver damage. Healthcare providers should monitor liver function tests regularly during treatment.
- Zavesca may cause peripheral neuropathy, which can manifest as tingling, numbness, or pain in the hands and feet. Patients should report any symptoms of neuropathy to their healthcare provider promptly.
- Zavesca commonly causes gastrointestinal side effects such as diarrhea, nausea, and abdominal pain. Patients should maintain adequate hydration and report severe or persistent gastrointestinal symptoms to their healthcare provider.
- Zavesca may cause fetal harm if used during pregnancy. Women of childbearing age should use effective contraception while taking Zavesca and avoid pregnancy. Additionally, it is not known whether Zavesca is excreted in human breast milk, so breastfeeding should be avoided during treatment.
- Zavesca may interact with certain medications, including CYP3A4 inducers and inhibitors, which could affect its effectiveness or increase the risk of adverse reactions. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting Zavesca treatment.
What documents are required to import ZAVESCA to India?
ZAVESCA (miglustat) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from the Doctor
- Import permit if applicable
Is ZAVESCA available in India?
ZAVESCA (miglustat capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Zavesca in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ZAVESCA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of ZAVESCA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Zavesca 100 mg price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Zavesca®?
Miglustat is a Generic Name for the trade name drug Zavesca®.
What is the Manufacturer’s Name of Zavesca®?
Zavesca® is manufactured by Actelion Pharmaceuticals, Inc.
Is Zavesca® approved by the FDA?
Yes, Zavesca® is approved by the FDA. Date of first approval: July 31, 2003.
Where can I get Zavesca® at the best price in India?
To get the best Zavesca price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Zavesca®, a medical prescription is needed from a treating physician.
What is the dosage and form of Zavesca® supplied?
Zavesca® is supplied as Capsules: 100 mg for oral administration.
What are the most common side effects of Zavesca®?
The most common side effects of Zavesca® are diarrhea, weight loss, stomach pain, gas, nausea, back pain, vomiting, headache, dizziness, weakness, vision problems, muscle cramps, constipation, dry mouth, indigestion, paresthesia, stomach bloating, and menstrual changes.
How much does Zavesca® cost in India?
The cost of Zavesca in India can vary. To procure this therapeutic drug legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Zavesca®?
Store Zavesca at controlled room temperature (20-25°C / 68-77°F) in its original packaging away from light and moisture.
Is it safe to buy Zavesca® online in India?
Yes, one can buy Zavesca online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Zavesca injections through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.